Shares of Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) have been assigned a consensus recommendation of "Hold" from the six analysts that are currently covering the stock, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $16.67.
A number of analysts recently commented on the stock. Truist Financial dropped their price target on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research note on Friday, April 11th. Macquarie raised their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. Finally, UBS Group decreased their price target on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research note on Monday, May 12th.
Check Out Our Latest Report on Pediatrix Medical Group
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of MD. American Century Companies Inc. boosted its stake in Pediatrix Medical Group by 628.2% in the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company's stock worth $22,820,000 after buying an additional 1,500,485 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Pediatrix Medical Group during the 1st quarter valued at about $8,024,000. Oberweis Asset Management Inc. purchased a new stake in Pediatrix Medical Group during the 4th quarter worth approximately $6,122,000. Renaissance Technologies LLC increased its holdings in shares of Pediatrix Medical Group by 117.4% in the 4th quarter. Renaissance Technologies LLC now owns 838,800 shares of the company's stock valued at $11,005,000 after acquiring an additional 453,000 shares during the last quarter. Finally, Nomura Holdings Inc. acquired a new position in Pediatrix Medical Group during the 4th quarter valued at approximately $3,882,000. Hedge funds and other institutional investors own 97.71% of the company's stock.
Pediatrix Medical Group Trading Up 0.9%
Shares of Pediatrix Medical Group stock traded up $0.12 on Friday, hitting $12.76. 607,206 shares of the company's stock traded hands, compared to its average volume of 720,419. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.81 and a quick ratio of 1.81. Pediatrix Medical Group has a one year low of $7.47 and a one year high of $17.67. The firm's 50-day moving average price is $13.83 and its two-hundred day moving average price is $13.87. The stock has a market capitalization of $1.10 billion, a PE ratio of -12.63, a price-to-earnings-growth ratio of 0.85 and a beta of 1.25.
Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a negative net margin of 4.17% and a positive return on equity of 17.43%. The firm had revenue of $458.36 million for the quarter, compared to analysts' expectations of $451.44 million. During the same period in the prior year, the firm earned $0.20 EPS. The business's revenue was down 7.4% on a year-over-year basis. On average, research analysts expect that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.
About Pediatrix Medical Group
(
Get Free ReportPediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Read More

Before you consider Pediatrix Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.
While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.